Insider Transactions in Q1 2025 at Precigen, Inc. (PGEN)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 14
2025
|
Randal J Kirk |
BUY
Exercise of conversion of derivative security
|
Indirect |
174,825
+0.27%
|
-
|
|
Mar 14
2025
|
Jeffrey B Kindler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
87,412
+14.38%
|
-
|
|
Mar 14
2025
|
James S Turley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
87,412
+12.79%
|
-
|
|
Mar 14
2025
|
Fred Hassan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
87,412
+7.04%
|
-
|
|
Mar 14
2025
|
Vinita D Gupta Director |
BUY
Exercise of conversion of derivative security
|
Direct |
87,412
+13.17%
|
-
|
|
Mar 14
2025
|
Cesar L Alvarez Director |
BUY
Exercise of conversion of derivative security
|
Direct |
87,412
+11.2%
|
-
|
|
Mar 14
2025
|
Steven Frank Director |
BUY
Exercise of conversion of derivative security
|
Direct |
87,412
+7.12%
|
-
|
|
Mar 13
2025
|
Nancy H Agee Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,471
+39.34%
|
$32,471
$1.74 P/Share
|
|
Mar 13
2025
|
Randal J Kirk |
BUY
Grant, award, or other acquisition
|
Indirect |
57,471
+0.09%
|
$57,471
$1.74 P/Share
|
|
Mar 13
2025
|
Jeffrey B Kindler Director |
BUY
Grant, award, or other acquisition
|
Direct |
39,655
+8.39%
|
$39,655
$1.74 P/Share
|
|
Mar 13
2025
|
James S Turley Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,919
+6.6%
|
$35,919
$1.74 P/Share
|
|
Mar 13
2025
|
Fred Hassan Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,206
+3.28%
|
$36,206
$1.74 P/Share
|
|
Mar 13
2025
|
Vinita D Gupta Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,206
+6.9%
|
$36,206
$1.74 P/Share
|
|
Mar 13
2025
|
Cesar L Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,919
+5.6%
|
$35,919
$1.74 P/Share
|
|
Mar 13
2025
|
Steven Frank Director |
BUY
Grant, award, or other acquisition
|
Direct |
28,735
+2.66%
|
$28,735
$1.74 P/Share
|
|
Jan 29
2025
|
Phil Tennant Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,441
-37.76%
|
$9,441
$1.3 P/Share
|
|
Jan 29
2025
|
Phil Tennant Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+50.0%
|
-
|
|
Jan 29
2025
|
Donald P. Lehr Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
20,844
-3.52%
|
$20,844
$1.3 P/Share
|
|
Jan 29
2025
|
Donald P. Lehr Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
54,000
+8.36%
|
-
|
|
Jan 29
2025
|
Rutul R Shah Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
47,151
-14.09%
|
$47,151
$1.3 P/Share
|
|
Jan 29
2025
|
Rutul R Shah Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+27.19%
|
-
|
|
Jan 29
2025
|
Helen Sabzevari President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
286,967
-9.42%
|
$286,967
$1.3 P/Share
|
|
Jan 29
2025
|
Helen Sabzevari President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
825,000
+21.31%
|
-
|
|
Jan 29
2025
|
Harry Thomasian Jr. Chief Financial Office |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+26.08%
|
-
|